BJP condemns Pragya Thakur’s remarks on Godse, drops her from defence panel

Agencies
November 28, 2019

New Delhi, Nov 28: Cracking the whip on its serial-offender MP Pragya Thakur, who hailed Mahatma Gandhi's assassin Nathuram Godse in Lok Sabha, The BJP on Thursday barred her from attending its parliamentary party meeting in the ongoing Parliament session and removed her from the consultative committee on defence.

BJP working president J P Nadda announced the disciplinary action against her and condemned the controversial Hindutva leader's remarks in a bid to defuse the political crisis triggered by her remarks in the Lok Sabha on Wednesday.

Nadda also said that Thakur will be removed from the consultative committee on defence, to which she was recently appointed.

"The statement given by MP Pragya Thakur is condemnable. BJP never supports such statement and we do not support this ideology. We have decided that Thakur will not attend meetings of BJP parliamentary party during the session," he told reporters.

Thakur created a controversy on Wednesday with her remark in the Lower House during DMK member A Raja's narration of a statement by Nathuram Godse before a court on why he killed Mahatma Gandhi.

However, after opposition members protested against Thakur's remarks, Lok Sabha Speaker Om Birla said only the DMK leader's speech during the discussion on the Special Protection Group (Amendment) Bill will go on record.

Opposition parties attacked the government, particularly Prime Minister Narendra Modi, alleging that the PM's "inaction" against her proves his latent support to "Godse's sinister thought".

The opposition party said Thakur's remarks were a "perfect representation" of the BJP's "deplorable hate politics".

"We are very clear about it that we condemn her statement and we do not support this ideology," Nadda, who was accompanied by Parliamentary Affairs Minister Pralhad Joshi, said.

During the Lok Sabha election campaign, Thakur had described Godse as a patriot, triggering a huge political storm.

Later, she had apologised for her statement.

However, Prime Minister Modi had said the remarks made about Gandhiji or Nathuram Godse were very bad and very wrong for society. "She has sought an apology but I would never be able to forgive her fully," he had said.

"Nathuram Godse was a 'deshbhakt', he is and will remain a 'deshbhakt'. Those calling him a terrorist should instead look at themselves. They will be given a befitting reply in this election," the controversial leader had said while attending a roadshow.

The BJP had immediately got into damage control and distanced itself from Thakur's statement and asked her to tender a public apology.

Comments

Ahmed Ali K.
 - 
Thursday, 28 Nov 2019

ಮಂಗನ ಕೈಯಲ್ಲಿ ಮಾಣಿಕ್ಯ ಕೊಟ್ಟಂತೆ ಆಗಿದೆ ಬಿಜೆಪಿ ಯವರು ಈ ಅವಿದ್ಯಾವಂತೆಗೆ ಡಿಫೆನ್ಸ್ ನ  ಕಾನ್ಸುಲೇಟಿವ್ ಸಮಿತಿ ಯ ಮೆಂಬರ್ ಮಾಡಿದ್ದು

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 7,2020

May 7: Two people, including a child, were killed and nearly 70 hospitalised after a gas leak at a chemical plant in Andhra Pradesh's Visakhapatnam in the wee hours of Thursday, officials said.

People in Gopalapatnam area, where the chemical plant, LG Polymers, is located, complained of irritation in eyes, breathlessness, nausea and rashes on their bodies.

District Collector V Vinay Chand said two people were killed due to the gas leak, while some are in a critical condition.

Close to 70 people have been admitted to the King George Hospital after for treatment, he said.

TV channels showed people lying unconscious on roads.

Teams of the National Disaster Response Force (NDRF) have rushed to the spot.

Reports said the gas leak has been contained.

Chief Minister Y S Jagan Mohan Reddy enquired about the incident and directed the Visakhapatnam district collector to ensure proper medical care for the affected people.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 11,2020

New Delhi, Jun 11: The death toll due to COVID-19 rose to 8,102 and the number of cases climbed to 2,86,579 in the country after it registered the highest single-day spike of 357 fatalities and 9,996 cases till Thursday 8 AM, according to the Union Health Ministry data.

The number of recoveries remained more than the active novel coronavirus cases for the second consecutive day.

The number of active cases stands at 1,37,448 while 1,41,028 people have recovered and one patient has migrated to another country, as per the data.   

"Thus, around 49.21 per cent patients have recovered so far," an official said.

The total number of confirmed cases include foreigners.

Of the 357 new deaths reported till Thursday morning, 149 were in Maharashtra, 79 in Delhi, 34 in Gujarat, 20 in Uttar Pradesh, 19 in Tamil Nadu, 17 in West Bengal, eight in Telangana, seven each in Madhya Pradesh and Haryana, four in Rajasthan, three each in Jammu and Kashmir and Karnataka, two each in Kerala and Uttarakhand, one each in Andhra Pradesh, Bihar and Himachal Pradesh.

Out of the total 8,102 fatalities, Maharashtra tops the tally with 3,438 deaths followed by Gujarat with 1,347 deaths, Delhi with 984, Madhya Pradesh with 427, West Bengal with 432, Tamil Nadu with 326, Uttar Pradesh with 321, Rajasthan with 259 and Telangana with 156 deaths.

The death toll reached 78 in Andhra Pradesh, 69 in Karnataka and 55 in Punjab. Jammu and Kashmir has reported 51 fatalities due to the coronavirus disease, while 52 deaths have been reported from Haryana, 33 from Bihar, 18 from Kerala, 15 from Uttarakhand, nine from Odisha and eight from Jharkhand.

Chhattisgarh and Himachal Pradesh have registered six COVID-19 fatalities each, Chandigarh has five while Assam has recorded four deaths so far. Meghalaya, Tripura and Ladakh have reported one COVID-19 fatality each, according to the ministry's data.

More than 70 per cent of the deaths are due to comorbidities, the ministry's website stated.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.